您的购物车当前为空
SARS-CoV-2 3CLpro-IN-18(Compound 3C)为一种共价SARS-CoV-2 3CLpro抑制剂,具有0.478 μM的IC50值。在Vero E6细胞中对SARS-CoV-2展现出2.499 μM的EC50抑制活性,并显示出较低的细胞毒性(CC50> 200 μM)。
SARS-CoV-2 3CLpro-IN-18(Compound 3C)为一种共价SARS-CoV-2 3CLpro抑制剂,具有0.478 μM的IC50值。在Vero E6细胞中对SARS-CoV-2展现出2.499 μM的EC50抑制活性,并显示出较低的细胞毒性(CC50> 200 μM)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
SARS-CoV-2 3CLpro-IN-18 相关产品
| 产品描述 | SARS-CoV-2 3CLpro-IN-18 (Compound 3C) is a covalent inhibitor of SARS-CoV-2 3CLpro with an IC50 of 0.478 μM. It demonstrates inhibition of SARS-CoV-2 in Vero E6 cells, with an EC50 of 2.499 μM, and exhibits low cytotoxicity (CC50 > 200 μM) [1]. |
| 分子量 | 328.82 |
| 分子式 | C17H13ClN2OS |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容